Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1395705

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1395705

Europe Human Milk Oligosaccharides Market Size, Share & Industry Trends Analysis Report By Application, By Type (2'FL, 3'FL, 3'SL, and 6'SL), By Concentration (Neutral, and Acidic), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Europe Human Milk Oligosaccharides Market would witness market growth of 22.4% CAGR during the forecast period (2023-2030).

The market is expected to witness significant revenue generation during the forecast period, owing to an increase in application scope in functional food & beverages and infant formula, rapid technological advancement in the product line, rise in health awareness, and rapid development of the dairy industry. HMOs are essential components of human milk that are available in a variety of concentrations and compositions. They are novel ingredients that require regulatory approval. With the upsurge in demand for HMOs, two HMOs have undergone the novel food safety assessment in Europe, resulting in a positive evaluation outcome and approval by the European Commission.

HMOs have been used in infant formula and human milk for a prolonged period. The compositions, however, differ, and HMOs are not found in other foods. The path to the market for new and novel HMOs as a dietary supplement is to have GRAS self-affirmed for use in food and subsequently use it in the same form as a dietary supplement. 2'-O-fucosyllactose, 2'-fucosyllactose, and lacto-N-neotetraose have all received such notices.

The German consumer base is known for its health-conscious preferences. HMO-enriched fresh milk aligns with the trend of seeking functional and health-promoting ingredients, attracting consumers looking for products with added nutritional value. Fresh milk with added HMOs can extend beyond infant nutrition to include products aimed at maternal health during pregnancy and lactation. This expansion broadens the HMOs in dairy products. The aforementioned factors will drive the market growth in this region.

The Germany market dominated the Europe Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $54,123.6 Thousand by 2030. The UK market is exhibiting a CAGR of 21.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 23.2% during (2023 - 2030).

Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A)

Scope of the Study

Market Segments covered in the Report:

By Application

  • Infant Formula
  • Functional Food & Beverages
  • Food Supplements
  • Others (Clinical Nutrition & Pharmaceuticals)

By Type

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

By Concentration

  • Neutral
  • Acidic

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Koninklijke DSM N.V.
  • BASF SE
  • Chr. Hansen Holding A/S
  • DuPont de Nemours, Inc.
  • Nestle S.A
  • Inbiose NV
  • Biosynth AG
  • Abbott Laboratories
  • Royal FrieslandCampina N.V.
  • Dextra Laboratories Ltd (ICE S.p.A)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Human Milk Oligosaccharides Market, by Application
    • 1.4.2 Europe Human Milk Oligosaccharides Market, by Type
    • 1.4.3 Europe Human Milk Oligosaccharides Market, by Concentration
    • 1.4.4 Europe Human Milk Oligosaccharides Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials and Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.4 Porter Five Forces Analysis

Chapter 5. Europe Human Milk Oligosaccharides Market, by Application

  • 5.1 Europe Infant Formula Market, by Country
  • 5.2 Europe Functional Food & Beverages Market, by Country
  • 5.3 Europe Food Supplements Market, by Country
  • 5.4 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country

Chapter 6. Europe Human Milk Oligosaccharides Market, by Type

  • 6.1 Europe 2'FL Market, by Country
  • 6.2 Europe 3'FL Market, by Country
  • 6.3 Europe 3'SL Market, by Country
  • 6.4 Europe 6'SL Market, by Country

Chapter 7. Europe Human Milk Oligosaccharides Market, by Concentration

  • 7.1 Europe Neutral Market, by Country
  • 7.2 Europe Acidic Market, by Country

Chapter 8. Europe Human Milk Oligosaccharides Market, by Country

  • 8.1 Germany Human Milk Oligosaccharides Market
    • 8.1.1 Germany Human Milk Oligosaccharides Market, by Application
    • 8.1.2 Germany Human Milk Oligosaccharides Market, by Type
    • 8.1.3 Germany Human Milk Oligosaccharides Market, by Concentration
  • 8.2 UK Human Milk Oligosaccharides Market
    • 8.2.1 UK Human Milk Oligosaccharides Market, by Application
    • 8.2.2 UK Human Milk Oligosaccharides Market, by Type
    • 8.2.3 UK Human Milk Oligosaccharides Market, by Concentration
  • 8.3 France Human Milk Oligosaccharides Market
    • 8.3.1 France Human Milk Oligosaccharides Market, by Application
    • 8.3.2 France Human Milk Oligosaccharides Market, by Type
    • 8.3.3 France Human Milk Oligosaccharides Market, by Concentration
  • 8.4 Russia Human Milk Oligosaccharides Market
    • 8.4.1 Russia Human Milk Oligosaccharides Market, by Application
    • 8.4.2 Russia Human Milk Oligosaccharides Market, by Type
    • 8.4.3 Russia Human Milk Oligosaccharides Market, by Concentration
  • 8.5 Spain Human Milk Oligosaccharides Market
    • 8.5.1 Spain Human Milk Oligosaccharides Market, by Application
    • 8.5.2 Spain Human Milk Oligosaccharides Market, by Type
    • 8.5.3 Spain Human Milk Oligosaccharides Market, by Concentration
  • 8.6 Italy Human Milk Oligosaccharides Market
    • 8.6.1 Italy Human Milk Oligosaccharides Market, by Application
    • 8.6.2 Italy Human Milk Oligosaccharides Market, by Type
    • 8.6.3 Italy Human Milk Oligosaccharides Market, by Concentration
  • 8.7 Rest of Europe Human Milk Oligosaccharides Market
    • 8.7.1 Rest of Europe Human Milk Oligosaccharides Market, by Application
    • 8.7.2 Rest of Europe Human Milk Oligosaccharides Market, by Type
    • 8.7.3 Rest of Europe Human Milk Oligosaccharides Market, by Concentration

Chapter 9. Company Profiles

  • 9.1 Inbiose NV
    • 9.1.1 Company Overview
    • 9.1.2 SWOT Analysis
  • 9.2 Biosynth AG
    • 9.2.1 Company Overview
    • 9.2.2 SWOT Analysis
  • 9.3 Dextra Laboratories Ltd (ICE S.p.A)
    • 9.3.1 Company Overview
  • 9.4 Koninklijke DSM N.V.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Trials and Approvals:
      • 9.4.5.2 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 BASF SE
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Product Launches and Product Expansions:
    • 9.5.1 SWOT Analysis
  • 9.6 Chr. Hansen Holding A/S
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segment & Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Trials and Approvals:
      • 9.6.5.2 Acquisition and Mergers:
  • 9.7 DuPont de Nemours, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
    • 9.7.6 SWOT Analysis
  • 9.8 Nestle S.A
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
    • 9.8.6 SWOT Analysis
  • 9.9 Abbott Laboratories
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Product Launches and Product Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. Royal FrieslandCampina N.V.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Partnerships, Collaborations, and Agreements:
      • 9.10.5.2 Trials and Approvals:
    • 9.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 2 Europe Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 3 Partnerships, Collaborations and Agreements- Human Milk Oligosaccharides Market
  • TABLE 4 Product Launches And Product Expansions- Human Milk Oligosaccharides Market
  • TABLE 5 Acquisition and Mergers- Human Milk Oligosaccharides Market
  • TABLE 6 Trials and Approvals- Human Milk Oligosaccharides Market
  • TABLE 7 Europe Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 8 Europe Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 9 Europe Infant Formula Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 10 Europe Infant Formula Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 11 Europe Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 12 Europe Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 13 Europe Food Supplements Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 14 Europe Food Supplements Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 15 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 16 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 17 Europe Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 18 Europe Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 19 Europe 2'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 20 Europe 2'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 21 Europe 3'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 22 Europe 3'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 23 Europe 3'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 24 Europe 3'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 25 Europe 6'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 26 Europe 6'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 27 Europe Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 28 Europe Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 29 Europe Neutral Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 30 Europe Neutral Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 31 Europe Acidic Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 32 Europe Acidic Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 33 Europe Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 34 Europe Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 35 Germany Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 36 Germany Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 37 Germany Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 38 Germany Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 39 Germany Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 40 Germany Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 41 Germany Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 42 Germany Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 43 UK Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 44 UK Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 45 UK Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 46 UK Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 47 UK Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 48 UK Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 49 UK Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 50 UK Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 51 France Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 52 France Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 53 France Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 54 France Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 55 France Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 56 France Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 57 France Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 58 France Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 59 Russia Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 60 Russia Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 61 Russia Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 62 Russia Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 63 Russia Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 64 Russia Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 65 Russia Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 66 Russia Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 67 Spain Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 68 Spain Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 69 Spain Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 70 Spain Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 71 Spain Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 72 Spain Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 73 Spain Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 74 Spain Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 75 Italy Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 76 Italy Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 77 Italy Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 78 Italy Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 79 Italy Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 80 Italy Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 81 Italy Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 82 Italy Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 83 Rest of Europe Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 84 Rest of Europe Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 85 Rest of Europe Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 86 Rest of Europe Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 87 Rest of Europe Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 88 Rest of Europe Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 89 Rest of Europe Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 90 Rest of Europe Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 91 Key Information - Inbiose NV
  • TABLE 92 Key Information - Biosynth AG
  • TABLE 93 Key Information - Dextra Laboratories Ltd
  • TABLE 94 Key Information - Koninklijke DSM N.V.
  • TABLE 95 Key Information - BASF SE
  • TABLE 96 Key Information - Chr. Hansen Holding A/S
  • TABLE 97 Key Information -DuPont de Nemours, Inc.
  • TABLE 98 Key Information - Nestle S.A
  • TABLE 99 Key Information - Abbott Laboratories
  • TABLE 100 Key Information - Royal FrieslandCampina N.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!